Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
105 USD | -1.41% |
|
+0.19% | +14.28% |
06-25 | Blueprint Medicines Insider Sold Shares Worth $7,713,537, According to a Recent SEC Filing | MT |
06-13 | CStone Gets Green Light for Local Manufacturing of AYVAKIT in China | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.15% | 6.67B | |
+28.68% | 52.73B | |
+37.49% | 39B | |
-9.22% | 38.52B | |
+28.71% | 30.38B | |
-12.26% | 26.39B | |
+11.76% | 26.08B | |
+46.01% | 14.15B | |
+32.92% | 12.6B | |
-5.46% | 11.51B |
- Stock Market
- Equities
- BPMC Stock
- News Blueprint Medicines Corporation
- Transcript : Blueprint Medicines Corporation, Q2 2022 Earnings Call, Aug 02, 2022